Lobe Sciences Ltd.
LOBEF
$0.04
$0.004.65%
OTC PK
| 08/31/2025 | 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -100.00% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -100.00% |
| Cost of Revenue | -- | -- | -- | -- | 911.11% |
| Gross Profit | -- | -- | -- | -- | -129.70% |
| SG&A Expenses | 287.66% | 95.44% | 7.93% | 34.46% | -57.81% |
| Depreciation & Amortization | -- | -- | -- | -- | -100.00% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 188.77% | 186.09% | 1.84% | -7.33% | -67.91% |
| Operating Income | -188.77% | -186.09% | -1.84% | -15.58% | 43.30% |
| Income Before Tax | 20.66% | -157.69% | -10.85% | -39.90% | -132.52% |
| Income Tax Expenses | -- | -- | -- | -- | -84.33% |
| Earnings from Continuing Operations | 21.58% | -157.69% | -10.85% | -39.90% | -100.21% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 31.59% | -123.53% | -10.85% | -39.90% | -100.21% |
| EBIT | -188.77% | -186.09% | -1.84% | -15.58% | 43.30% |
| EBITDA | -185.44% | -204.40% | -3.43% | -17.80% | 42.00% |
| EPS Basic | -323.23% | -33.33% | 53.57% | 35.85% | -2,503.08% |
| Normalized Basic EPS | -1,456.31% | -23.53% | 45.71% | 36.36% | -787.88% |
| EPS Diluted | -323.23% | -33.33% | 53.57% | 35.85% | -2,503.08% |
| Normalized Diluted EPS | -1,456.31% | -23.53% | 45.71% | 36.36% | -787.88% |
| Average Basic Shares Outstanding | -83.83% | 68.66% | 135.50% | 119.50% | -92.29% |
| Average Diluted Shares Outstanding | -83.83% | 68.66% | 135.50% | 119.50% | -92.29% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |